Jazz Pharmaceuticals plc Overview
Jazz Pharmaceuticals plc Target Price
Analysts' 12-month price predictions for JAZZ.
Share Price
$109.29
Average Target Price
$182.00
66.5% upside
66.5% upside2 analysts in the last 4 months
High: $188 | Low: $176
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2024-05-02 | RBC CapitalDaniel Busb | $176 | 61% upside |  |
| 2024-03-20 | Piper SandlerDavid Amsellem | $188 | 72% upside | |
| 2022-12-09 | Goldman Sachs | $190 | 73.8% upside | |
| 2022-11-10 | Goldman Sachs | $192 | 75.7% upside | |
| 2022-11-10 | RBC Capital | $207 | 89.4% upside | |
| 2022-06-20 | Piper SandlerDavid Amsellem | $193 | 76.6% upside | |
| 2022-06-13 | UBSAshwani Verma | $194 | 77.5% upside | |
| 2022-03-03 | NeedhamAmi Fadia | $215 | 96.7% upside | |
| 2022-01-20 | Truist FinancialGreg Fraser | $200 | 83% upside | |
| 2022-01-14 | Stifel NicolausAnnabel Samimy | $210 | 92.1% upside | |
| 2022-01-03 | BernsteinAaron Gal | $175 | 60.1% upside | |
| 2021-11-10 | Bank of America SecuritiesJason Gerberry | $193 | 76.6% upside | |
| 2021-10-06 | Cantor FitzgeraldBrandon Folkes | $210 | 92.1% upside | |
| 2021-10-05 | CitigroupNavann Ty | $200 | 83% upside | |
| 2021-06-22 | BarclaysBalaji Prasad | $250 | 128.7% upside | |
| 2021-06-18 | UBSEsther Rajavelu | $234 | 114.1% upside | |
| 2021-05-10 | Cowen & Co.Ken Cacciatore | $200 | 83% upside | |